Novel Biomarkers of Kidney Disease in Advanced Heart Failure: Beyond GFR and Proteinuria

Bethany Roehm, Meredith McAdams, S. Susan Hedayati

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose: Kidney disease is a common finding in patients with heart failure and can significantly impact treatment decisions and outcomes. Abnormal kidney function is currently determined in clinical practice using filtration markers in the blood to estimate glomerular filtration rate, but the manifestations of kidney disease in the setting of heart failure are much more complex than this. In this manuscript, we review novel biomarkers that may provide a more well-rounded assessment of kidney disease in patients with heart failure. Recent Findings: Galectin-3, ST2, FGF-23, suPAR, miRNA, GDF-15, and NAG may be prognostic of kidney disease progression. L-FABP and suPAR may help predict acute kidney injury (AKI). ST2 and NAG may be helpful in diuretic resistance. Summary: Several biomarkers may be useful in determining prognosis of long-term kidney disease progression, prediction of AKI, and development of diuretic resistance. Further research into the mechanisms of kidney disease in heart failure utilizing many of these biomarkers may lead to the identification of therapeutic targets.

Original languageEnglish (US)
JournalCurrent heart failure reports
DOIs
StateAccepted/In press - 2022
Externally publishedYes

Keywords

  • Biomarkers
  • Cardiorenal
  • Heart failure
  • Kidney disease
  • Kidney function

ASJC Scopus subject areas

  • Emergency Medicine
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Novel Biomarkers of Kidney Disease in Advanced Heart Failure: Beyond GFR and Proteinuria'. Together they form a unique fingerprint.

Cite this